PT  - JOURNAL ARTICLE
ED  - ,
TI  - Update on drugs for hyperactivity in childhood
AID  - 10.1136/dtb.2007.45537
DP  - 2007 May 01
TA  - Drug and Therapeutics Bulletin
PG  - 37--40
VI  - 45
IP  - 5
4099  - http://dtb.bmj.com/content/45/5/37.short
4100  - http://dtb.bmj.com/content/45/5/37.full
SO  - Drug Ther Bull2007 May 01; 45
AB  - Relevant BNF section: 4.4In 2001, we concluded that methylphenidate or dexamfetamine can be useful adjunctive therapy for children with severe hyperactivity in whom non-drug approaches alone have been inadequate.1 Since then, ▼atomoxetine (pronounced a-toe-moks-e-teen; Strattera – Lilly) and three modified-release formulations of methylphenidate have been launched for attention deficit hyperactivity disorder (ADHD). Here we reconsider drugs for ADHD in childhood, focusing on the newer products.